1 / 1

Supplement f ig . 4 Effects of Activin A on osteoblastic differentiation of HPDLC-3O and -3Q

Supplement f ig . 4 Effects of Activin A on osteoblastic differentiation of HPDLC-3O and -3Q. (B). (A). mRNA expression (/ b -actin ). Area (mm 2 ). **. **. Area (mm 2 ). mRNA expression (/ b -actin ). **. **. (C). AR. VK. AR. AR. **. Ca +ACV. **. Ca +ACV. Ca. ACV.

Télécharger la présentation

Supplement f ig . 4 Effects of Activin A on osteoblastic differentiation of HPDLC-3O and -3Q

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supplement fig. 4 Effects of Activin A on osteoblastic differentiation of HPDLC-3O and -3Q (B) (A) mRNA expression (/b-actin) Area (mm2) ** ** Area (mm2) mRNA expression (/b-actin) ** ** (C) AR VK AR AR ** Ca +ACV ** Ca +ACV Ca ACV Cont Ca ACV Cont (-) (-) (-) (-) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) Ca Ca Ca Ca VK VK AR (-) (-) (-) (-) (-) (-) (-) (-) ACV ACV ACV ACV Area (mm2) VK ** ** AR #4 #4 #8 #8 #1 #1 #5 #5 #2 #2 #6 #6 #3 #3 #7 #7 Area (mm2) VK Supplemental Fig. 4 Effects of Activin A on osteoblastic differentiation of HPDLC-3O and -3Q. HPDLC-3O, derived from a premolar of 20-year-old female (upper) and -3Q, derived from a premolar of a 21-year-old female (bottom) were cultured in 10%FBS/MEM as a control, 10%FBS/MEM + 1 mM CaCl2 (Ca), or 10%FBS/MEM + 100 ng/ml Activin A (ACV), or 10%FBS/MEM + 1 mM CaCl2 + 100 ng/ml Activin A (Ca + ACV). Mineralization was visualized by Alizarin Red S staining (AR) and von Kossa staining (VK) on Day 21 and staining area was quantitated. (B) Gene expression changes for OCN, RUNX2 and BSP in HPDLC-3O (upper) and -3Q (bottom) cultured in one of the aforementioned conditions was examined by quantitative RT-PCR analysis. The expression levels of these genes were normalized against -actin expression, and the results are shown as the fold-increase of the control. (C) HPDLC-3O (upper) and -3Q (bottom) were cultured under different timeframes and durations in the presence or absence of ActivinA treatment with or without 1 mM CaCl2 for 3 weeks. The schedules of Activin A exposure are described in Fig. 4C. After culturing, mineralization was visualized by AR and VK staining methods on day 21, and positively-stained areas were quantified and described graphically. Values are the mean ± SD from three independent experiments. *P < 0.05 , **P < 0.01.These results support the findings presented in Fig. 4. Area (mm2) ** ** AR AR AR AR VK VK VK VK Area (mm2) * * * ** * *

More Related